Published on 04.04.2024 in Vol 11 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54386, first published November 08, 2023.

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

Liselot N van den Berg^{1, 2}

; Cynthia Hallensleben^{1, 2}

; Lisa AE Vlug^{1, 2}

; Niels H Chavannes^{1, 2}

; Anke Versluis^{1, 2}

Article Authors Cited by Tweetations (3) Metrics

Liselot N van den Berg ^{1, 2} , MSc ; Cynthia Hallensleben ^{1, 2} ; Lisa AE Vlug ^{1, 2} , MSc ; Niels H Chavannes ^{1, 2} , MD, PhD ; Anke Versluis ^{1, 2} , PhD

¹ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands

² National eHealth Living Lab, Leiden, Netherlands

Corresponding Author:

Liselot N van den Berg, MSc
Department of Public Health and Primary Care
Leiden University Medical Center
Hippocratespad 21
Leiden, 2300 RC
Netherlands
Phone: 31 71 526 57 61
Email: L.N.van_den_Berg@lumc.nl